122 related articles for article (PubMed ID: 8695173)
41. Infiltrating lobular carcinoma of the breast: systemic treatment.
Farese SA; Aebi S
Breast Dis; 2008-2009; 30():45-52. PubMed ID: 19850995
[TBL] [Abstract][Full Text] [Related]
42. Hypercalcaemia in patients with advanced mammary cancer.
Galasko CS; Burn JI
Br Med J; 1971 Sep; 3(5774):573-7. PubMed ID: 5571456
[TBL] [Abstract][Full Text] [Related]
43. [Combination therapy of patients with locally advanced breast cancer].
Manziuk LV; Komov DV; Khaĭlenko VA; Artamonova EV; Mikhina ZP; Ermilova VD; Abashin SIu
Vopr Onkol; 2001; 47(6):740-3. PubMed ID: 11826501
[TBL] [Abstract][Full Text] [Related]
44. [Potential indications for helical tomotherapy in breast cancers].
Lamberth F; Guilbert P; Gaillot-Petit N; Champagne C; Looten-Vieren L; Nguyen TD
Cancer Radiother; 2014 Jan; 18(1):7-14. PubMed ID: 24314856
[TBL] [Abstract][Full Text] [Related]
45. [Monotherapy with clodronate for tumor-induced hypercalcemia].
Harjung H; Fritze D
Dtsch Med Wochenschr; 1990 Jan; 115(2):48-52. PubMed ID: 2136827
[TBL] [Abstract][Full Text] [Related]
46. [Malignant hypercalcemia after treatment of breast cancer].
Bernard JD; Rimailho J; Pourrut JC; Hoff J; Bècue J
J Gynecol Obstet Biol Reprod (Paris); 1992; 21(7):775-7. PubMed ID: 1469233
[TBL] [Abstract][Full Text] [Related]
47. Acquired lymphangiectasis after breast conservation treatment for breast cancer: report of a case.
Tasdelen I; Gokgoz S; Paksoy E; Yerci O; Cetintas SK; Demiray M; Samsa V
Dermatol Online J; 2004 Jul; 10(1):9. PubMed ID: 15347491
[TBL] [Abstract][Full Text] [Related]
48. The presence of proliferative breast disease with atypia does not significantly influence outcome in early-stage invasive breast cancer treated with conservative surgery and radiation.
Fowble B; Hanlon AL; Patchefsky A; Freedman G; Hoffman JP; Sigurdson ER; Goldstein LJ
Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):105-15. PubMed ID: 9747827
[TBL] [Abstract][Full Text] [Related]
49. The management of hypercalcaemia in advanced cancer.
Pettifer A; Grant S
Int J Palliat Nurs; 2013 Jul; 19(7):327-31. PubMed ID: 24273809
[TBL] [Abstract][Full Text] [Related]
50. Content of epidermal growth factor receptor in metastatic breast cancer: its role in endocrine sensitivity prediction.
Nesković-Konstantinović ZB; Nikolić-Vukosavljević DB; Branković-Magić MV; Mitrovic LB; Spuzić I
Neoplasma; 2000; 47(2):107-13. PubMed ID: 10985476
[TBL] [Abstract][Full Text] [Related]
51. Breast cancer: high resolution CT in association with spirometric tests in the assessment of post-radiation pulmonary fibrosis.
Sacco M; Murgante F; Attanasio S; Fossaceca R; Brambilla M; Krengli M; Carriero A
Radiol Med; 2005 Sep; 110(3):156-69. PubMed ID: 16200038
[No Abstract] [Full Text] [Related]
52. Quantitation of the renal effect of calcitonin in the hypercalcaemia of malignancy.
Hosking DJ; Heller SR
Eur J Clin Pharmacol; 1986; 31(1):27-31. PubMed ID: 3780823
[TBL] [Abstract][Full Text] [Related]
53. [Colorectal epidermoid carcinoma and paraneoplastic hypercalcemia].
Gatlez J; Hendlisz A; Legendre H; Sirtaine N; Debroux S; Awada A
Acta Clin Belg; 2007; 62(6):433-7. PubMed ID: 18351188
[TBL] [Abstract][Full Text] [Related]
54. Therapeutical approach of hypercalcemia in malignancy.
Duprez D; Rottiers R; Vermeulen A
Acta Clin Belg; 1983; 38(3):165-70. PubMed ID: 6225289
[No Abstract] [Full Text] [Related]
55. Denosumab in hypercalcemia of malignancy: a case series.
Dietzek A; Connelly K; Cotugno M; Bartel S; McDonnell AM
J Oncol Pharm Pract; 2015 Apr; 21(2):143-7. PubMed ID: 24415364
[TBL] [Abstract][Full Text] [Related]
56. Molecular markers of therapeutic resistance in breast cancer.
Zhou L; Luo Y; Li K; Tian L; Wang M; Li C; Huang Q
Hum Pathol; 2013 Jul; 44(7):1421-8. PubMed ID: 23434145
[TBL] [Abstract][Full Text] [Related]
57. [Malignancy-associated hypercalcemia].
Oura S
Nihon Rinsho; 2003 Jun; 61(6):1006-9. PubMed ID: 12806951
[TBL] [Abstract][Full Text] [Related]
58. [Two cases of stage IV breast cancer with severe hypercalcemia].
Ohsako T; Yamamoto Y; Kawazoe T; Inoue K; Nagamoto N; Yoshida Y; Nakahara O; Sakamoto N; Iwase H
Gan To Kagaku Ryoho; 2006 Feb; 33(2):223-6. PubMed ID: 16484860
[TBL] [Abstract][Full Text] [Related]
59. Typing breast cancer following primary chemotherapy.
Carder P
Histopathology; 1999 Dec; 35(6):584-5. PubMed ID: 10583584
[No Abstract] [Full Text] [Related]
60. Oral cancer-associated paraneoplastic syndromes.
Feller L; Wood NH; Khammissa RA; Chikte UM; Essop R; Meyerov R; Lemmer J
SADJ; 2010 Oct; 65(9):424-6. PubMed ID: 21180290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
